Monday, August 24, 2026
ExploreSearch
Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 27, 2026

Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026

View original at finance.yahoo.com
Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026 Awards Recognize Innovations in Infection Measures, AI-Driven Recovery and Surgeon Engagement across Asia Pacific…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Iodine-treated implants are designed to inhibit bacterial adhesion and reduce the risk of periprosthetic joint infection

    60% confidence

  • These awards reflect the strength of Zimmer Biomet's innovation and the relevance of our solutions across Asia Pacific

    60% confidence

  • Periprosthetic joint infection is a serious complication affecting approximately 1-2% of primary procedures

    60% confidence

  • WalkAI is designed to flag patients who may not be recovering as expected and enable earlier clinical intervention by identifying deviations in recovery between days 15 and 40 post-surgery

    60% confidence

  • Iodine helps prevent biofilm formation without contributing to antibiotic resistance

    60% confidence

  • WalkAI uses artificial intelligence to analyze real-world mobility data and predict a patient's 90-day gait speed following total knee replacement surgery

    60% confidence

  • Zimmer Biomet is focused on solving the most meaningful health care challenges and improving outcomes for patients across the Asia Pacific region through advanced implant technologies, data-driven recoveries, and improved surgeon engagement

    60% confidence

Cited in these Via News reports